Bristol-Myers Squibb - Company & Market Research Reports

Home /
Companies /
Bristol-Myers Squibb

Bristol-Myers Squibb is a pharmaceutical company that develops products for various diseases, such as oncology, virology, cardiovascular diseases, serious mental illness, and immunoscience. The company has delivered 12 new medicines to patients in the past 7 years. It also provides products for Alzheimer's disease, atherosclerosis/thrombosis, hepatitis, HIV/AIDS, solid organ transplant rejection, and a wide variety of other diseases and disorders. Bristol-Myers Squibb was founded in 1990 and is based in Uxbridge, United Kingdom.

REFINE BY

KEYWORD

CATEGORIES

Oncology Drugs 465
Immune Disorders Drugs 196
Cardiovascular Drugs 154
Biopharmaceuticals 132
Infectious Diseases Drugs 121
Central Nervous System Drugs 104
Endocrine and Metabolic Disorders Drugs 103
Drug Discovery 102
Musculoskeletal Disorders Drugs 94
Clinical Trials 90
Pharmaceuticals 88
Leukemia Drugs 83
Hematological Drugs 83
Liver and Kidney Disorders Drugs 74
Lymphoma Drugs 64
Dermatological Drugs 59
Diabetes Drugs 54
Skin Cancer Drugs 50
Brain Cancer Drugs 47
Mental Disorders Drugs 41
Lung Cancer Drugs 40
Respiratory Drugs 38
Immunosuppressive Drugs 36
Gastrointestinal Drugs 34
Drug Delivery 32
Pharmaceutical Intermediates 30
Liver Cancer Drugs 30
Infusions and Injectables 30
Pharmaceutical Manufacturing 27
Analgesics 26
Bladder Cancer Drugs 25
Drugs by Therapeutic Area 23
Antibiotics 23
Kidney Cancer Drugs 22
HIV/AIDS Drugs 22
Breast Cancer Drugs 18
Ovarian Cancer Drugs 17
Colon Cancer Drugs 17
Cervical Cancer Drugs 17
Pancreatic Cancer Drugs 17
Psoriasis Drugs 17
Prostate Cancer Drugs 16
Urological Disorders Drugs 16
Schizophrenia Drugs 15
Thyroid Cancer Drugs 14
Sexual and Reproductive Health Drugs 14
Cancer Vaccines 13
Over the Counter (OTC) Drugs 12
Biosimilars and Biosuperiors 10
Optical Disorders Drugs 8
Generic Drugs 8
Uterine Cancer Drugs 8
Alzheimer's Disease Drugs 8
Transdermal and Transmucosal Drug Delivery 7
Vaccines 7
Cough and Cold Drugs 6
Anti-Obesity Drugs 6
Anxiety Drugs 6
Company Reports 5
Pharmacoeconomics 3
Vitamins and Dietary Supplements 3
Addiction Disorders Drugs 2
Animal Pharmaceuticals 2
Asthma Drugs 2
Inhalers and Nebulisers 1
Anesthetic Drugs 1
Allergy Drugs 1
Bronchitis Drugs 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



284 reviews

2,388 Results (Page 23 of 120)
- Relevance
  Sort by

Chronic Kidney Disease Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031

 Report
January 2026
185 Pages
Global

From

€4026EUR$4,500USD£3,443GBP

Antimicrobial Therapeutics Market 2024-2028

 Report
June 2024
175 Pages
Global

From

€2237EUR$2,500USD£1,913GBP

Pharmaceutical Market Size, Share & Trends Analysis Report by Molecule Type, Product, Type, Disease, Route of Administration, Age Group, Distribution Channel, Region, and Segment Forecasts, 2026-2033

 Report
February 2026
150 Pages
Global

From

€5324EUR$5,950USD£4,553GBP

Brain Tumor Drugs Market Analysis & Forecast 2024-2034: Market; By Therapy; By Indication; By Distribution Channel; and By Region

 Report
October 2023
145 Pages
Global

From

€2818EUR$3,150USD£2,410GBP

Chronic Lymphocytic Leukemia (CLL) Market Opportunity Assessment, Epidemiology, Clinical Trials, Unmet Needs and Forecast to 2032

 Report
September 2023
65 Pages
Global

From

€8943EUR$9,995USD£7,648GBP

NEED HELP FINDING THE RIGHT PRODUCT? Olha will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Acute Myeloid Leukemia (AML) Market Opportunity Assessment, Epidemiology, Clinical Trials, Unmet Needs and Forecast to 2032

 Report
September 2023
79 Pages
Global

From

€8943EUR$9,995USD£7,648GBP

Brain Tumor Drugs Market Forecasts from 2023 to 2028

 Report
November 2023
140 Pages
Global

From

€3982EUR$4,450USD£3,405GBP

Ovarian Cancer Drugs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027 Segmented By Drug Class, By Tumor Type, By Distribution Channel, By Region

 Report
November 2022
117 Pages
Global

From

€4026EUR$4,500USD£3,443GBP

Vascular Endothelial Growth Factor (Vegf) Inhibitors Market 2024-2028

 Report
May 2024
178 Pages
Global

From

€2237EUR$2,500USD£1,913GBP

Scleroderma Therapeutics Market Report and Forecast 2023-2031

 Report
April 2023
160 Pages
Global

From

€4428EUR$4,949USD£3,787GBP

Anaplastic Thyroid Cancer Drugs Market 2024-2028

 Report
December 2023
151 Pages
Global

From

€2237EUR$2,500USD£1,913GBP

Scleroderma Diagnostics & Therapeutics Market - Global Forecast 2026-2032

 Report
August 2026
181 Pages
Global

From

€3172EUR$3,545USD£2,713GBP

€3524EUR$3,939USD£3,014GBP

US Kidney Cancer Therapeutics and Diagnostics Market to 2028

 Report
October 2023
85 Pages
United States

From

€4026EUR$4,500USD£3,443GBP

Dermatology OTC Medications Market Report 2026

 Report
February 2026
250 Pages
Global

From

€4017EUR$4,490USD£3,436GBP

Immuno-Oncology Clinical Trials Market Report 2023-2033

 Report
September 2023
249 Pages
Global

From

€4781EUR$5,530USD£3,950GBP

Diabetes Drug Market Size and Share Analysis - Growth Trends and Forecast Report 2025-2033

 Report
March 2025
200 Pages
Global

From

€2228EUR$2,490USD£1,905GBP

Celiac Diseases Drugs Market 2025-2029

 Report
March 2025
212 Pages
Global

From

€2237EUR$2,500USD£1,913GBP

Bispecific Antibodies - Global Strategic Business Report

 Report
August 2026
104 Pages
Global

From

€5234EUR$5,850USD£4,476GBP

Squamous Non-Small Cell Lung Cancer Therapeutics Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application

 Report
October 2024
99 Pages
Global

From

€3500EUR$4,190USD£3,098GBP

Lung Cancer Diagnosis and Therapeutics Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type

 Report
October 2024
118 Pages
Global

From

€3500EUR$4,190USD£3,098GBP

2,388 Results (Page 23 of 120)
- 1
- 21
- 22
- 23
- 24
- 25

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.